AU1872001A - Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release - Google Patents

Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release

Info

Publication number
AU1872001A
AU1872001A AU18720/01A AU1872001A AU1872001A AU 1872001 A AU1872001 A AU 1872001A AU 18720/01 A AU18720/01 A AU 18720/01A AU 1872001 A AU1872001 A AU 1872001A AU 1872001 A AU1872001 A AU 1872001A
Authority
AU
Australia
Prior art keywords
inhibitors
human
acid derivatives
hydroxamic acid
tnf release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18720/01A
Inventor
Andrew Faller
Elizabeth Farrant
Anne-Geraldine Gervois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU1872001A publication Critical patent/AU1872001A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
AU18720/01A 1999-12-14 2000-12-13 Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release Abandoned AU1872001A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9929527.1A GB9929527D0 (en) 1999-12-14 1999-12-14 Novel compounds
GB9929527 1999-12-14
PCT/GB2000/004772 WO2001044221A1 (en) 1999-12-14 2000-12-13 Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release

Publications (1)

Publication Number Publication Date
AU1872001A true AU1872001A (en) 2001-06-25

Family

ID=10866288

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18720/01A Abandoned AU1872001A (en) 1999-12-14 2000-12-13 Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release

Country Status (3)

Country Link
AU (1) AU1872001A (en)
GB (1) GB9929527D0 (en)
WO (1) WO2001044221A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
GB9414157D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Medical use
GB9601042D0 (en) * 1996-01-17 1996-03-20 Smithkline Beecham Plc Medical use
US5672598A (en) * 1995-03-21 1997-09-30 The Procter & Gamble Company Lactam-containing hydroxamic acids
GB9513331D0 (en) * 1995-06-30 1995-09-06 British Biotech Pharm Matrix metalloproteinase inhibitors
WO1998043959A1 (en) * 1997-03-28 1998-10-08 Zeneca Limited Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
BR9814147A (en) * 1997-11-12 2000-10-03 Darwin Discovery Ltd "derivatives of carboxylic and hydroxamic acid having inhibitory activity of mmp and tnf"
GB9813451D0 (en) * 1998-06-22 1998-08-19 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
WO2001044221A1 (en) 2001-06-21
GB9929527D0 (en) 2000-02-09

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
HK1048247B (en) Stable carotene-xanthophyll beadlet compositions and methods of use
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU6340600A (en) Telomerase inhibitors and methods of their use
AU7079700A (en) Improved stable formulations of ace inhibitors, and methods for preparation thereof
AU5652001A (en) Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
AU3622600A (en) Metalloproteinases and methods of use therefor
AU2003222083A1 (en) Acid and ester compounds and methods of using the same
AU2575201A (en) Use of hsp27 as an anti-inflammatory agent
AU7958100A (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
HK1045260B (en) Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
HUP0102776A3 (en) Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
AU5428700A (en) Acrylic acid derivatives, use of the same and intermediates for the preparation thereof
AU3501700A (en) Human endokine alpha and methods of use
IL149364A0 (en) Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
AU5499401A (en) Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
AU1955201A (en) Insecticide targets and methods of use
AU1872001A (en) Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release
AU6866700A (en) Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
AU2003279800A1 (en) Sulfatases and methods of use thereof
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase